Full-Time

Territory Manager

Confirmed live in the last 24 hours

Outset Medical

Outset Medical

501-1,000 employees

Dialysis treatment and training solutions

Biotechnology
Healthcare

Compensation Overview

$110kAnnually

Junior, Mid

Indiana, USA + 1 more

More locations: Michigan, USA

The job is focused on the territories of Michigan and Indiana.

Category
Field Sales
Sales & Account Management
Required Skills
Sales

You match the following Outset Medical's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree or equivalent experience required
  • Minimum of 2 years sales experience preference for experience in healthcare or capital sales
  • Excellent communication and interpersonal skills
  • Proven successful track record in medical equipment sales
  • Ability to travel up to 75%, dependent upon account distribution
  • Selling in disruptive environments and influencing behavior change
  • Success in introducing new technologies to the market is a plus
Responsibilities
  • Implement targeted business plans supporting the Area Sales Manager and console growth
  • Build clinical and administrative support through technical presentations, executive meetings, marketing events and Tablo demos.
  • Generate key stakeholder interest with Director of Dialysis, Biomed, Purchasing Director, Supply Chain Director, Pharmacy, Director of ICU, Nurse Educators, and Intensivists
  • Drive sales activities through multiple stakeholders in non-Tablo, contracted RIDN accounts
  • Build interest in Tablo via office visits, LTAC discovery calls, educational dinners, educational symposiums, and fellowship journal clubs
  • Responsible for sales activities in new product launches, implementation, and go-lives
  • Represent ASM in various sales meetings
  • Build support from physicians, clinical staff and administration for Tablo
  • Effectively manage transition of initial sale and installation driving procedural volume and growth
  • Achieve quarterly sales targets
  • Develop expert level knowledge of Dialysis
  • Make economic case for Tablo purchase
  • Handle communications and administrative follow-up
  • Ensure adherence to Company Quality policy
Desired Qualifications
  • Display enthusiasm, ambition and a strong work ethic
  • Must show ability to excel in a high-energy, fast-paced environment
  • Must be detail oriented with excellent analytical and problem-solving skills
  • Maintain a sense of urgency, work effectively under pressure, and be able to multi-task

Outset Medical improves dialysis treatment by offering the Tablo system, which integrates with electronic medical record (EMR) platforms to streamline workflows and manage patient data effectively. They provide educational programs and hands-on training for dialysis professionals, including a Vascular Access Program and a Bridge Program to support facilities transitioning to in-house dialysis services. Outset Medical stands out by delivering a comprehensive approach to dialysis care across hospitals, outpatient clinics, and home settings. Their goal is to enhance the quality of care for dialysis patients through effective training and integrated technology.

Company Size

501-1,000

Company Stage

IPO

Total Funding

$542.8M

Headquarters

San Jose, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of home dialysis solutions aligns with Outset Medical's offerings.
  • FDA's accelerated approval process benefits Outset Medical's innovative product developments.
  • Growing emphasis on cybersecurity highlights Outset Medical's FIPS 140-3 validation for Tablo.

What critics are saying

  • Class action lawsuits pose financial and reputational risks to Outset Medical.
  • Shipment pause of TabloCart with Prefiltration could disrupt supply chains and customer trust.
  • Retiring $200 million in prior debt may strain resources and impact growth investments.

What makes Outset Medical unique

  • Outset Medical's Tablo system integrates seamlessly with EMR platforms for efficient data management.
  • The company offers a unique Vascular Access Program to enhance staff expertise in cannulation.
  • Outset Medical's Bridge Program supports facilities transitioning to in-house dialysis services.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision

Life Insurance/AD&D

FSA & HSA

401k

Parental leave

Pet insurance

Tuition reimbursement

PTO

Company events

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

2%
The Healthcare Technology Report
Jan 27th, 2025
Outset Medical Raises $169 Million Through Private Placement Financing

In addition to the private placement, Outset secured a $100 million term loan from Perceptive Advisors, with an option for $25 million more.

Benzinga
Jan 6th, 2025
Outset Medical Secures $169M Financing

Outset Medical announced a $169 million private placement financing, issuing 843,908 shares of Series A Non-Voting Convertible Preferred Stock at $200 per share. The company also secured up to $125 million in debt financing maturing in 2030, with plans to retire $200 million in prior debt. The financing was led by PFM Health Sciences and Perceptive Advisors. Outset reported unaudited Q4 revenue of $29 million and 2024 revenue of $113 million. The transactions are expected to close by January 8, 2025.

Business Wire
Oct 18th, 2024
Berman Tabacco Announces that it has Filed a New Class Action Complaint Against Outset Medical, Inc. with an Expanded Class Period

Berman Tabacco announces that it has filed a new class action complaint against Outset Medical, Inc. with an Expanded Class Period.

Corsec
Sep 25th, 2024
Outset Medical Validates Tablo System to FIPS 140-3

To achieve this milestone, Outset partnered with Corsec, completing the validation at a Level 1 as seen in certificate #4812.

PR Newswire
Sep 3rd, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM

Then, on August 2, 2023, Outset Medical issued a press release announcing a "Shipment Pause of TabloCart with Prefiltration Pending 510(k) Clearance."